posted                      

quote:

---

A new analysis of randomized controlled trials evaluating probiotics in the treatment of irritable bowel syndrome (IBS) has found that Bifantis(R),

Bifidobacterium infantis 35624, the sole ingredient in Align(R) (manufactured by Procter & Gamble), is the only probiotic currently able to demonstrate significant improvement in IBS symptoms based upon a properly designed research study.

Researchers at the University of Michigan conducted the review to evaluate the safety, efficacy and tolerability of probiotics for IBS in randomized controlled trials and found that, with the exception of the Bifidobacterium

infantis 35624 studies, most were not designed in a way that made the data possible to validate. The review data were presented this week at the annual American College of

Gastroenterology (ACG) conference taking place in Philadelphia, PA.

---

Posts: 2150 | From Maryland | Registered: Dec 2007  |  IP: Logged |